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Letters to the
Editor
Off-pump versus conventional
coronary artery bypass grafting:
Randomized studies
To the Editor:
We congratulate Puskas and colleagues1
on their prospective, randomized study
assessing the efficacy of off-pump coro-
nary artery bypass grafting (CABG) rel-
ative to conventional CABG techniques.
We are pleased to see that their early
in-hospital findings are similar to the re-
sults of the Beating Heart Against Car-
dioplegic Arrest Study (BHACAS) 1 and
2 trials conducted by our group.2 Indeed,
since our first randomized study3 several
others have been published, some with
respectable sample sizes,4-5 and the Sur-
gical Management of Arterial Revascu-
larization Therapies (SMART) trial is the
latest in this series. We appreciate that
the available presence of all these trials
somehow reduces the “visibility” of each
of them, particularly if they are not the
first or the largest.
Puskas and colleagues1 (a total of 17
authors of the SMART trial) in the intro-
duction of their article state, “Moreover,
most previous studies have failed to ade-
quately address legitimate concerns about
the completeness of revascularization pro-
vided or to document the quality of anas-
tomoses.” Furthermore, they state, “There
have been no published reports comparing
OPCAB versus CABG with CPB among
randomly assigned patients unselected for
coronary anatomy, ventricular function, or
comorbidities.” This is simply not the case.
The BHACAS 1 trial was the first ever
randomized study, carried out between
March 1997 and August 1998. The ran-
domization rate was 32%, and all patients
underwent complete coronary revascular-
ization. The limited number of grafts per
patient was the result of stringent selection
criteria that excluded those who needed
grafting of the distal branches of the cir-
cumflex artery, because this was regarded
as too difficult at the beginning of our
experience with off-pump CABG surgery.
After establishing the safety of the tech-
nique, we then moved to BHACAS 2 (Sep-
tember 1998 through November 1999), in
which coronary anatomy was not an exclu-
sion criterion. We excluded from the study
emergency and salvage operations and pa-
tients with such potentially confounding
variables as previous stroke, renal failure,
and reoperative CABG, which might have
affected the interpretation of clinical out-
come. Nevertheless, the off-pump and con-
ventional CABG groups of BHACAS 2
included 48% and 43% of urgent in-hospi-
tal unstable angina referrals, 17% and 13%
of those with previous myocardial infarc-
tion less than 14 days before surgery, 24%
and 23% of patients with ejection fraction
less than 50%, and 32% and 30% of pa-
tients with diabetes, respectively. The over-
all randomization rate was 63%, a much
higher percentage than the 43% reported by
Puskas and colleagues.1 More importantly,
we achieved a homogenous distribution of
risk factors between groups. This unfortu-
nately did not happen in Puskas and col-
leagues’ SMART trial,1 where for example
the values for previous stroke history were
9% and 1% (P  .018) in the on-and off-
pump groups, respectively.
The BHACAS trials also provided mid-
term clinical outcomes, with particular at-
tention to mortality and cardiac-related
events, both as single trial or pooled anal-
ysis of the 401 randomized patients, and
concluded that off-pump CABG signifi-
cantly reduces early in-hospital morbidity
without compromising outcome in the first
1 to 3 years after surgery relative to con-
ventional on-pump technique. We believe
that when bringing to light new evidence it
is important to present in a complete and
objective fashion what is already available
in the literature: “Give to Caesar what is
Caesar’s.”
R. Ascione, MD
G. D. Angelini, MD
Bristol Heart Institute
Bristol Royal Infirmary,
Bristol, United Kingdom
The Editor welcomes submissions for
possible publication in the Letters to the
Editor section that consist of commen-
tary on an article published in the Jour-
nal or other relevant issues. Authors
should:
● Include no more than 500 words of text,
three authors, and five references
● Type with double-spacing
● See http://jtcs.ctsnetjournals.org/misc/
ifora.shtml for detailed submission
instructions.
● Submit the letter electronically via
jtcvs.editorialmanager.com.
Letters commenting on an article pub-
lished in the JTCVS will be considered if
they are received within 6 weeks of the
time the article was published. Authors
of the article being commented on will be
given an opportunity to offer a timely
response (2 weeks) to the letter. Authors
of letters will be notified that the letter
has been received. Unpublished letters
cannot be returned.
300 The Journal of Thoracic and Cardiovascular Surgery ● January 2004
References
1. Puskas JD, Williams WH, Duke PG, Staples
JR, Glas KE, Marshall JJ, et al. Off-pump
coronary artery bypass grafting provides
complete revascularization with reduced
myocardial injury, transfusion requirements,
and length of stay: a prospective randomized
comparison of two hundred unselected pa-
tients undergoing off-pump versus conven-
tional coronary artery bypass grafting. J Tho-
rac Cardiovasc Surg. 2003;125:797-808.
2. Angelini GD, Taylor FC, Reeves BC, As-
cione R. Early and midterm outcome after
off-pump and on-pump surgery in Beating
Heart Against Cardioplegic Arrest Studies
(BHACAS 1 and 2): a pooled analysis of two
randomised controlled trials. Lancet. 2002;
359:1194-9.
3. Ascione R, Lloyd CT, Underwood MJ, Lotto
AA, Pitsis AA, Angelini GD. Economic out-
come of off-pump coronary artery bypass
surgery: a prospective randomized study. Ann
Thorac Surg. 1999;68:2237-42.
4. van Dijk D, Mierich AP, Jansen EW, Nathoe
HM, Suyker WJ, Diephius JC, et al. Early
outcome after off-pump versus on-pump cor-
onary bypass surgery: results from a random-
ized study. Circulation. 2001;104:1761-6.
5. Diegeler A, Doll N, Rauch T, Haberer D,
Walther T, Falk V, et al. Humoral immune
response during coronary artery bypass graft-
ing: a comparison of limited approach, “off-
pump” technique, and conventional cardio-
pulmonary bypass. Circulation. 2000;102(19
Suppl 3):III95-100.
doi:10.1016/S0022-5223(03)00802-X
Reply to the Editor:
Drs Ascione and Angelini have written to
emphasize the contributions they have pre-
viously made in conducting and reporting
randomized clinical trials of off-pump cor-
onary artery bypass grafting (CABG) ver-
sus CABG with cardiopulmonary bypass
(CPB). Indeed, these authors and their co-
workers have made numerous contribu-
tions to our understanding of patient out-
comes with these two surgical techniques.
Among their contributions is a series of
publications reporting various outcome
variables from two groups of selected pa-
tients randomized to undergo OPCAB or
conventional CABG/CPB. As they have
noted in their own letter to the Editor, the
first of these groups of patients was se-
lected to exclude those requiring grafts to
the distal branches of the left circumflex
artery, whereas the second group was se-
lected to exclude patients with previous
stroke and renal failure, as these were con-
sidered potentially confounding variables.
Both studies reported important advantages
of OPCAB over conventional CABG/CPB
and were landmark publications. Neither
rigorously documented the completeness of
revascularization. Indeed, BHACAS 2 re-
ported that 70% of CPB patients versus
56% of OPCAB patients had 3 grafts or
more; this difference (the manuscript does
not state whether this was a statistically
significant difference) was especially noted
in grafts to the lateral wall of the left ven-
tricle. The mean number of grafts per pa-
tient in each group was not reported.1
In the SMART trial,2 my coauthors (to
each of whom I am grateful) and I sought
to demonstrate that OPCAB could be
safely applied to the general population of
patients referred for elective surgical coro-
nary revascularization and that an equiva-
lently optimal revascularization could be
achieved in both groups. Patients were not
excluded on the basis of any coronary anat-
omy, ventricular dysfunction, or comor-
bidities, including prior stroke or renal fail-
ure. Indeed we believed it important to
randomize “all comers,” and we did so.
Thus, this trial compared outcomes among
truly unselected patients referred for non-
emergency CABG. (Among the numerous
demographic variables tracked, incidence
of prior stroke was regrettably different
between the randomized groups. This is a
simple function of sample size.) We be-
lieved it important to document the optimal
revascularization that should be performed
for each patient before randomization. The
grafts actually performed were then com-
pared with those intended, creating a for-
mal index of completeness of revascular-
ization (ICOR), which was found to be
virtually identical between groups. The
ICOR was also similar between groups for
the lateral wall of the left ventricle, docu-
menting that OPCAB with modern stabi-
lizing devices could provide complete re-
vascularization of all areas of the heart in
unselected patients. Other end points, in-
cluding serum levels of myocardial en-
zymes, transfusion requirement, and length
of stay, strongly favored the OPCAB
group, consistent with the findings of pre-
vious randomized trials in selected pa-
tients.
We look forward to reporting angio-
graphic graft patency and longer term out-
comes from these randomized cohorts as
those data become available, building on
the important foundation that Drs Ascione,
Angelini,1 Van Dijk,3 Diegeler,4 Czerny,5
Zamvar,6 and others have laid.
“I prefer nothing more than that I
should be true to myself and they to
themselves.”
—Julius Caesar, letter
to Cicero, quoted in Cicero, Letters
to Atticus, 9.16.2.
John D. Puskas, MD
Associate Professor of Surgery
(Cardiothoracic)
Emory University
Crawford Long Hospital
Atlanta, GA 30308
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